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Edited by Veli-Pekka LehtoAbstract Suppressor of T-cell receptor signalling 1 and 2 (Sts-1
and 2) negatively regulate the endocytosis of receptor tyrosine ki-
nases. The UBA domain of Sts-2 and SH3-dependent Cbl-binding
are required for this function. Sts-1 and -2 also possess a PGM
domain, which was recently reported to exhibit tyrosine phospha-
tase activity. Here, we demonstrate that the PGM of Sts-1, but
not of Sts-2, dephosphorylates the EGFR at multiple tyrosines
thereby terminating its signalling and endocytosis. In contrast
to Sts-2 the UBA of Sts-1 did not contribute signiﬁcantly to
receptor stabilization. Thus, although Sts-1 and Sts-2 are struc-
turally highly homologous and both inhibit ligand-induced EGFR
degradation, their mechanisms of action diﬀer signiﬁcantly. As a
consequence, Sts-1-containing receptor complexes are inactive,
whereas Sts-2-containing complexes are signalling competent.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Receptor tyrosine kinase (RTK) signalling promotes
growth, survival, proliferation, migration and diﬀerentiation
in mammalian cells in response to extracellular stimuli [1]. Li-
gand-binding initiates the dimerization of the cognate recep-
tors and the activation of their kinase domains. Consequent
autophosphorylation on multiple tyrosines within the cytosolic
tail of the receptors creates docking sites for a variety of adap-
tor and eﬀector proteins containing phosphotyrosine-binding
domains. They in turn trigger the intracellular propagation
of the extracellular signal that ﬁnally results in the activation
of target genes in the nucleus [1]. Duration and amplitude of
signalling are tightly controlled in order to avoid aberrant acti-
vation that can lead to uncontrolled cell growth, migration,
transformation or proliferation and is frequently associated
with developmental defects or tumorigenesis [2].
Dephosphorylation of the receptor by phosphatases is the
most rapid and eﬃcient way for transient signal termination
[3]. Permanent inactivation of the EGFR is achieved by its
internalization and sorting into lysosomes where it is degraded*Corresponding author. Address: Biocenter Innsbruck, Fritz-Pregl-
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doi:10.1016/j.febslet.2007.08.077by lysosomal proteases [2]. To this end the receptor needs to be
ubiquitinated by the E3-ligase Cbl, which is recruited to the
autophosphorylation site Tyr1045 of the receptor and via the
adaptor protein Grb2 that binds to phosphorylated Tyr1068.
The Ub-moieties attached to the receptor are recognized by
a number of endocytic adaptor proteins that mediate the trans-
port along the endolysosomal route [4].
Suppressors of T-cell receptor signalling (Sts) 1 and 2 are
Cbl-interacting proteins that have been found to protect
EGFR and PDFGR from lysosomal degradation [5,6]. While
Sts-1 is ubiquitously expressed in mammalian organisms Sts-
2 expression is conﬁned to the hematopoietic lineage [7,8].
Sts-1 and 2 share about 40% sequence identity. Both proteins
possess a N-terminal Ub-associated (UBA) domain, a SH3 do-
main, that mediates binding to the proline-rich motif of Cbl,
and a C-terminal phosphoglycerate mutase (PGM) domain
that mediates dimerization of Sts-1/2 and is otherwise of un-
known function [5,6]. The UBA domain of Sts-2 was found
to be required for the stabilizing eﬀect on EGFR. It has been
proposed that Sts-1 and -2 bind to the ubiquitinated receptor
thereby competing with other UDB-containing endocytic
adaptor proteins such as the epsins or Eps15 that would sort
the ubiquitinated receptor to the lysosomes [5]. Accordingly,
overexpression of Sts-2 led to prolonged EGFR signalling
and cellular transformation [5]. In addition, the UBA domain
of Sts-1 and -2 mediate E2-mediated self-monoubiquitination
that results in the inactivation of their Ub-binding ability by
inducing intramolecular UBA/Ub interactions [9,10]. Sts-1
and -2 are also critical regulators of T-cell activation. Mice
lacking Sts-1 and -2 are hyperresponsive to T-cell stimulation
and show hyperactivation of signaling proteins downstream
of the T-cell receptor (TCR) including ZAP70 [7].
Here, we show that in contrast to Sts-2 the UBA domain of
Sts-1 is not involved in stabilization of activated EGFR. How-
ever, the PGM domain of Sts-1, but not Sts-2, dephosphoryl-
ates the EGFR and allows its escape from Cbl-mediated
downregulation. Though closely related in domain architec-
ture and amino acid sequence Sts-1 and Sts-2 exploit diﬀerent
strategies of regulating EGFR signalling.2. Experimental procedures
2.1. Reagents, cells, plasmids and antibodies
Constructs for FLAG-tagged Sts-1 and Sts-2 have been de-
scribed recently [9]. Phosphataseinactive mutants of Sts-1 and
Sts-2 have been generated by site-directed mutagenesis ofblished by Elsevier B.V. All rights reserved.
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of Sts-2 to alanines.
Antibodies anti-FLAG (M2 and M5) antibodies from Sigma
and anti-GST antibodies from Santa Cruz. For immunopre-
cipitation from HeLa and HEK 293T-cells the following
antibodies were used: EGFR: anti-EGFR 528 (Santa Cruz);
FLAG-tagged proteins: M5 (Sigma); Cbl: anti-Cbl RF. Phos-
photyrosine-speciﬁc EGFR antibodies were purchased from
Cell Signalling and anti-phosphotyrosine (pY99), anti-Erk2
and anti-phospho-Erk2 from Santa Cruz.
For overexpression experiments, HEK 293T-cells were
transfected using Lipofectamine Reagent (Invitrogen) andanti-EGFR (329)150
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Human EGF was purchased from Peprotech.
2.2. Immunoprecipitation
HEK 293T or HeLa cells were transfected with the indicated
constructs, lysed 24–48 posttransfection for 10 min on ice in ly-
sis buﬀer (50 mM HEPES, 150 mM NaCl, 1 mM EDTA,
1 mM EGTA, 10% glycerol, 1% Triton X-100, 25 mM NaF,
10 lM ZnCl2, pH 7.5) containing protease inhibitors (aproti-
nin, leupeptin, and PMSF) and ortho-vanadate. Cell lysates
were collected, centrifuged for 15 min (13 000 rpm) to removeTCL
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indicated antibody and Immunosorb Protein A beads (Medi-
cago, Sweden) for >3 h at +4 C. After incubation, the sephar-
ose matrix was washed 3 times with lysis buﬀer and bound
proteins were eluted by boiling the samples for 5 min with Lae-
mmli buﬀer containing 5% b-mercaptoethanol.2.3. Confocal microscopy
Hela cells were seeded onto coverslips and transfected with
FLAG-Sts-1 or FLAG-Sts-1 RH/AA or left untransfected.
After serum starvation for 8 h, the cells were stimulated for
5 min with 25 ng/ml EGF. Cells were ﬁxed with 4% PFA, per-
meabilized with digitonin and stained for EGF receptor with a
monoclonal mouse antibody 528 (Santa Cruz) and for FLAG-
Sts-1 using a polyclonal anti-FLAG antibody (Sigma, 1:300).
Secondary antibodies conjugated with ﬂuorochromes (anti-
rabbit-FITC and anti-mouse-Cy3, Jackson Immunoresearch)A
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Fig. 2. Sts-1 dephosphorylates endogenous EGFR at multiple tyrosines. (A)
PGM. Highly conserved residues are highlighted in yellow and the PGM/AcP
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the beads with FLAG peptide, added to the EGFR beads and incubated for 3
and immunoblotting using an phosphotyrosine-speciﬁc antibody (pY99).were used to visualize the primary antibodies. Images were pre-
pared using a Zeiss 510 Meta confocal microscope.2.4. Internalization assay
Hela cells were transfected either FLAG tagged Sts-1, Sts-1
RH/AA, Sts-1 UBA* or empty vector (control) and GFP as a
transfection control in 10 cm cell culture dishes. After 24 h
cells were split into 12 well dishes and starved overnight in ser-
um-free medium. The next day cycloheximide (20 lg/ml) was
added to the cells 2 h before they were left unstimulated or
were incubated with EGF (25 ng/ml) for 5, 15 and 30 min at
37 C. After stimulation cells were harvested using accutase
(PAA), blocked for 15 min in 4% BSA/PBS on ice and incu-
bated with PE-coupled anti-EGFR antibody (BD biosciences)
for 30 min to detect cellsurface EGFR. For each sample,
10,000 GFP-positive cells were analyzed using the Epics
XL ﬂow cytometer (Beckman-Coulter). Mean ﬂuorescenceanti-pY99
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Fig. 3. The phosphatase activity of Sts-1 is required for its ability to
inhibit EGFR degradation and internalization. (A) Overexpression of
Sts-1 UBA* has the same stabilizing eﬀect on EGFR as the Sts-1 wild
type. In contrast Sts-1 RH/AA is unable to inhibit receptor degrada-
tion. Hela cells transfected with the indicated constructs were starved
and stimulated with 25 ng/ml EGF for 5 min or left unstimulated.
Total cell lysates were analyzed by SDS–PAGE and immunoblotting.
(B) Internalization of endogenous EGFR was monitored in HeLa cells
transfected with control vector, Sts-1 wild type, Sts-1 RH/AA or Sts-1
UBA*. Sts-1 wild type and the Ub-binding deﬁcient Sts-1 UBA*
stabilized EGFR at the cell surface whereas Sts-1 RH/AA expressing
cells internalized the receptor with a similar eﬃciency as the control
cells. EGFR residing at the cell surface after 0, 5, 15 and 30 min of
EGF stimulation (25 ng/ml) was quantiﬁed ﬂow cytometry using a PE-
coupled EGFR antibody. The expression levels of transfected proteins
were checked by immunoblotting. The data represent the means ±
S.E.M. of three experiments.3. Results and discussion
In order to characterize the diﬀerential mechanisms underly-
ing Sts-1- and Sts-2-dependent inhibition of EGFR endocyto-
sis we analyzed the behaviour of endogenous EGFR in the
absence and presence Sts-1 (Fig. 1A) and Sts-2 (Fig. 1B). Upon
stimulation of HeLa cells with 25 ng/ml EGF overexpressed
FLAG-Sts-1, FLAG-Sts-2 and endogenous Sts-1 (HeLa cells
do not contain Sts-2) were recruited into complexes with
endogenous EGFR. Additional transfection of Cbl led to in-
creased recruitment of Sts-1/2 ([5] and data not shown). More-
over, overexpression of Sts-1 and Sts-2 led to a marked
inhibition in the receptor downregulation after stimulation
with EGF. These results conﬁrm previous observations that
Sts-1 and -2 are recruited via Cbl into activated EGFR com-
plexes and inhibit EGFR downregulation [5]. However, when
we analyzed the phosphorylation status of EGFR after stimu-
lation with EGF we detected a dramatic loss of tyrosine phos-
phorylation of EGFR upon overexpression of Sts-1 (Fig. 1A).
This eﬀect was not observed in case of Sts-2 (Fig. 1B). We
additionally analysed endogenous Sts-1 using confocal micros-
copy. In unstimulated HeLa cells Sts-1 showed a diﬀuse cyto-
solic localization (Fig. 1D, upper panel). Treatment of the cells
with 25 ng/ml EGF lead to the redistribution into vesicular
structures that also contained EGFR (lower panel).
The C-terminal domain of Sts-1 and Sts-2 resembles mem-
bers of the phosphoglycerate mutase/acidic phosphatase fam-
ily which act as phosphatases or phosphotransferases [11]. An
alignment of the amino acid sequences of Sts-1/2 from diﬀer-
ent species and human PGM reveals that the overall identity
is low, but the signature motif of the PGM/AcP family, com-
prising two histidines (H) and two arginines (R), are highly
conserved in the Sts-1-proteins (Fig. 2A, involved residues
are labelled with asterisks). We mutated Arg390 and His391
in Sts-1 (Sts-1 RH/AA) and Arg364 and His365 in Sts-2
(Sts-2 RH/AA). After expression in HEK 293T cells we ob-
served that the Sts-1 RH/AA mutant did not aﬀect EGFR
phosphorylation (Fig. 2B), while the corresponding mutations
in Sts-2 (Sts-2 RH/AA) did not aﬀect receptor phosphoryla-
tion (not shown). These data are consistent with a recent re-
port of Mikhailik et al. who solved the crystal structure of the
Sts-1 PGM domain and showed that it possesses phosphatase
activity which was required for the ability of Sts-1 to regulate
TCR signaling in T-cells [12]. On contrary, Sts-2-though con-
taining all catalytically active residues – showed only mar-
ginal phosphatase activity in vitro, when compared to the
activity of Sts-1 [12]. Interestingly, the active site of Sts-1/2 re-
quires HHRR residues, which is the characteristic two-step
catalytic mechanism of phosphoglyserate mutase/acid phos-
phatase family enzymes. Indeed, prostatic acid phosphatases
were shown to dephosphorylate a wide range of phosphory-
lated substrates including ATP, ADP pyrophosphate and
large tyrosine phosphorylated peptides including proteins
such as the ErbB2 receptor [11,13,14]. However, the catalytic
mechanism of PGM enzymes appears to be diﬀerent from the
prototypical tyrosine phosphatase, which have cysteine-based
catalytic sites [3].Classical protein-tyrosine phosphatases exhibit a high degree
of substrate speciﬁcity and often dephosphorylate only a sub-
set of phosphorylated tyrosins present on proteins [15,16]. This
site-selectivity allows a modulation of the downstream signal-
ling events. We wanted to know whether Sts-1 preferentially
acts on speciﬁc tyrosines or unspeciﬁcally dephosphorylates
the EGFR. Therefore, we overexpressed Sts-1 or Sts-1 RH/
AA in Hela cells and analyzed the phosphorylation pattern
of endogenous EGFR using antibodies speciﬁc for individual
phosphorylated tyrosines in the cytoplasmic region of EGFR.
We found that Sts-1 wild type but not Sts-1 RH/AA potently
dephosphorylated all tested tyrosines including Y845, Y992
(PLCc-binding site), Y1045 (Cbl-binding site), Y1068 (Grb2
and Gab1) and Y1173 (PLCc and Shc) (Fig. 2B). Sts-2 in con-
trast, did not aﬀect the phosphorylation of any tested tyrosine
(data not shown). We next wanted to conﬁrm that the eﬀect of
Sts-1 on EGFR is direct or mediated by another protein. We
therefore puriﬁed phosphorylated EGFR from EGF-treated
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with Sts-1 or Sts-1 RH/AA that had been puriﬁed from starved
HEK 293T-cells (Fig. 2C). Under these conditions Sts-1 po-
tently dephosphorylated EGFR while Sts-1 RH/AA was
completely inactive, suggesting that EGFR is a direct target
of Sts-1.
Sts-2 was proposed to stabilize EGFR by interfering with
the Ub-dependent transport machinery and its ability to bind
to Ub via its N-terminal UBA domain was essential for block-
ing receptor downregulation [5,9]. Given the fact that Sts-1
caused dephosphorylation of the receptor and Sts-1 RH/AA
signiﬁcantly aﬀected EGFR levels we wondered about the role
of the Sts-1 UBA-domain in receptor stabilization. We ﬁrst
analyzed receptor degradation in the presence of Sts-1 wild
type (Sts-1), Sts-1 phosphatase mutant (Sts-1 RH/AA) or
Ub-binding deﬁcient Sts-1 UBA mutant (Sts-1-UBA*) in HeLa
cells (Fig. 3A). Overexpression of Sts-1 wild type and Sts-1
UBA* lead to stabilization of EGFR upon stimulation with
25 ng/ml EGF, whereas the phosphatase-inactive mutant Sts-
1 RH/AA allowed a normal receptor degradation suggesting
that the phosphatase activity of the PGM domain is princi-
pally responsible for the inhibition of receptor degradation.
We next analyzed the contribution of UBA and PGM domains
to the internalization of endogenous EGFR by ﬂow cytometry.
As shown in Fig. 3B, overexpression of Sts-1 wild type resulted
in the stabilization of the receptor at the cell surface upon cell
stimulation with 25 ng/ml EGF. Mutations in the UBA-do-
main of Sts-1 did not aﬀect this ability signiﬁcantly. In pres-
ence of the phosphatase-inactive mutant Sts-1 RH/AA the
receptor was removed from the cell surface to a similar extent
as in the control cells.A
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Fig. 4. Sts-1 phosphatase activity prevents Cbl-mediated EGFR downregu
complexes. HeLa cell lysates expressing the indicated constructs were subjecte
by SDS–PAGE and immunoblotting. (B) Sts-1 overexpression suppresse
expressing the indicated constructs were subjected to immunoprecipitatio
immunoblotting. (C) Cbl is a direct target of Sts-1 phosphatase activity. Ph
immunoprecipitation and incubated for 30 min at 37 C with FLAG-Sts-1 w
the proteins.The results presented above suggest a model in which Sts-1
blocks EGFR signalling, internalization and degradation by
dephosphorylating the receptor thereby removing the docking
sites for the downstream eﬀectors. This model was further cor-
roborated by the observation that Sts-1 overexpression lead to
the loss of Cbl from EGFR complexes (Fig. 4A). Interestingly,
at the same time Sts-1 was still present in the complexes indi-
cating that once recruited to the receptor Sts-1 can stay asso-
ciated with the receptor independently of Cbl. Though this is
in agreement with the ability of Sts-1 to dephosphorylate acti-
vated EGFR in the absence of Cbl in vitro (Fig. 2C), to date
we do not have further experimental evidence for a direct bind-
ing or Cbl-independent way of association between Sts-1 and
EGFR under physiological conditions.
Lastly, we studied whether Cbl, which is phosphorylated
upon EGF or T-cell receptor stimulation [17,18], is dephos-
phorylated by Sts-1. Cbl-phosphorylation can be mediated
by Src, Fyn, Yes and Syk kinases and several RTKs depending
on the cellular context [19] [18] and was shown to be required
for its function as Ub E3-ligase and adaptor protein [18,20].
Overexpression of Sts-1, but not Sts-1 RH/AA, in cells led to
potent dephosphorylation of endogenous Cbl (Fig. 4B). To
avoid the inﬂuence of EGFR dephosphorylation on the Cbl-
phosphorylation status we puriﬁed phosphorylated Cbl from
EGF-stimulated Hela cells and incubated it with Sts-1 or
Sts-1 RH/AA in the same way as described above with EGFR.
As shown in Fig. 4C, in addition to EGFR, Sts-1 dephospho-
rylates and thus inactivates Cbl. In this way Sts-1 recruitment
results in termination of both Ub-dependent and -independent
internalization pathways. It remains to be determined to which
extent EGFR signals are emitted before the Cbl/Sts-1 complexanti-pY99
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However, at endogeous levels it seems that Sts-1 is present in
EGFR-positive endosom populations indicating that it may
act as a negative feed-back mechanism which may be involved
in slowing down endocytic processes and/or inhibit signalling
competence of the EGFR associated complexes.
Taken together, this report describes an unexpected diﬀer-
ence between the two related proteins Sts-1 and Sts-2. Upon
cell stimulation both proteins are recruited into activated
EGFR receptor complexes via the E3 ligase Cbl and potently
inhibit receptor endocytosis upon overexpression. However,
whereas Sts-2 requires a functional UBA domain to achieve
receptor stabilization, Sts-1 does so by dephosphorylating
the receptor as well as the negative regulator Cbl. In this
way Sts-1 not only terminates receptor downregulation but
also receptor signalling. As a consequence Sts-1-containing
receptor complexes are inactive whereas Sts-2-containing com-
plexes are signalling competent. In accordance, we have ob-
served that overexpression of Sts-2, but not Sts-1, leads to
oncogenic transformation in cultured ﬁbroblasts [5]. This func-
tional diﬀerence in Sts-1 and Sts-2 action might also explain
previous observations in T-cells whereby Sts-2 positively regu-
lated TCR-dependent gene transcription [6], while Sts-1 acted
as a suppressor of TCR signalling [7]. Yet, Sts-1 and Sts-2 were
shown cooperate to negatively regulate T-cell receptor signal-
ling in vivo since only upon deletion of both Sts-1 and Sts-2
there was a detectable phenotype observed, which included
hyperphosphorylation of Zap-70 and increase proliferation
of T-cells [7]. Future studies on the interplay between Sts-1
and Sts-2 as well as the importance of the diﬀerent domains
of Sts-1 and Sts-2 will be essential to delineate their distinct
biological functions in cells.
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